1. Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial. (March 2023) Authors: Louis, Edouard; Resche-Rigon, Matthieu; Laharie, David; Satsangi, Jack; Ding, Nik; Siegmund, Britta; D'Haens, Geert; Picon, Laurence; Bossuyt, Peter; Vuitton, Lucine; Irving, Peter; Viennot, Stephanie; Lamb, Christopher A; Pollok, Richard; Baert, Filip; Nachury, Maria; Fumery, Mathurin; Gilletta,... Journal: Lancet gastroenterology and hepatology Issue: Volume 8:Number 3(2023) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗